ReviewThe FEBS journal2026
Extracellular matrix and proteolysis: mechanisms driving irreversible changes and shaping cell behavior.
Review in The FEBS journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- The senescence-stiffening loop: Extracellular matrix remodeling, hypoperfusion, and mitochondrial dysfunction drive tissue aging.Cell metabolism · 2026Review
- Cooperation, Defection, and Collapse: A Multiscale Game Theory Framework for Emphysema Progression.Cells · 2026Review
- Rhomboid protease RHBDL2 is a calcium-activated suppressor of EGFR signalling in keratinocytes.Cellular and molecular life sciences : CMLS · 2026Article
- Adaptive Hyaluronic Acid Hydrogels for Regenerative Wound Healing: From Microenvironment Sensing to ECM Reprogramming and Precise Tissue Regeneration.Macromolecular rapid communications · 2026Review
- Interactions Between Epidermal Growth Factor-Containing Fibulin-Like Extracellular Matrix Protein 1 and Tissue Inhibitor of Metalloproteinases-3 and Relevance to Age-Related Macular Degeneration.Ophthalmology science · 2026Review
- Myeloid MMP14 couples extracellular proteolysis to inflammatory and metabolic remodeling during obesity.Cell reports · 2026Article
- Tetranectin: Molecular Mechanisms, Biological Functions and Clinical Implications.International journal of molecular sciences · 2026Review
- When proteases reshape barriers: Basement membrane remodelling in development, wound healing and tumour progression.The FEBS journal · 2026Review
- Proteolysis at the extracellular matrix interface: Molecular architects and regulators in health and disease.The FEBS journal · 2026Review
- Proteolytic remodelling of the extracellular matrix by pericytes.The FEBS journal · 2026Review
- Antibody-Drug Conjugates: Pharmacotherapeutic Properties and Future Perspectives.Pharmaceutics · 2026Review
- Extracellular matrix polysaccharides and glycoproteins in ovarian cancer: structural-functional macromolecular perspectives and potential exosome-derived biomarkers.Cell communication and signaling : CCS · 2026Review
- An animal component-free bioprocess for synthesizing 3D human matrix scaffolds using mesenchymal stromal cells.Frontiers in cell and developmental biology · 2026Article
- Deciphering the regulatory mechanism and therapeutic potential of ECM degradation in intervertebral disc degeneration via multi-omics integration.Frontiers in immunology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
The extracellular matrix (ECM) provides structural support and dynamic signaling cues, governing cellular behavior and tissue integrity. ECM remodeling, critically regulated by irreversible proteolysis, profoundly impacts development, homeostasis, and disease. This review examines the major families of ECM-degrading proteases-matrix metalloproteinases (MMPs), serine proteases, a disintegrin and metalloproteinases (ADAMs), metalloproteinase with thrombospondin motifs (ADAMTSs), and cysteine proteases-emphasizing their shared regulatory mechanisms and proteolytic activity in reshaping the tissue microenvironment. These proteases exhibit functional redundancy, particularly in the generation of matrikines, growth factors, and cytokines from common ECM substrates, all contributing to ECM softening. These overlaps in substrates and the resulting bioactive molecules amplify proteolysis within the tissue. The generated matrikines, growth factors, and cytokines further drive ECM remodeling through feedback loops, influencing the expression and activation of proteolytic enzymes. Despite these shared mechanisms, protease families demonstrate cell-specific functional specialization shaped by transcriptional programs, microenvironmental signals, and subcellular targeting, ensuring precise spatiotemporal proteolysis during processes such as development, wound healing, and immune responses. Dysregulation of this intricate proteolytic network contributes to chronic pathologies and cancer. Thus, understanding and targeting these processes is crucial for therapeutic intervention and the improved regulation of biological functions. Collectively, these insights reveal how irreversible ECM proteolysis orchestrates complex, context-dependent biological responses in both health and disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.